Long-term Survival Outcomes for Men Who Provided Ejaculate Specimens for Prostate Cancer Research: Implications for Patient Management
Darius Ashrafi, Peter Baade, John Yaxley, Matthew J Roberts, Scott Williams, Robert A Gardiner
European Urology Focus | ELSEVIER | Published : 2015
BACKGROUND: Determining whether men diagnosed with early prostate cancer (PCa) will live long enough to benefit from interventions with curative intent is difficult. Although validated instruments for predicting patient survival are available, these do not have clinical utility so are not used routinely in practice. OBJECTIVE: To test the hypothesis that volunteers who provided ejaculate specimens had a high survival rate at 10 and 15 yr and beyond. DESIGN, SETTING, AND PARTICIPANTS: A total of 290 patients investigated because of high serum prostate-specific antigen donated ejaculate specimens for research between January 1992 and May 2003. The median age at the time of ejaculation was 63.5..View full abstract
This research was funded by grants from the Australasian Urological Trust, Royal Brisbane and Women's Hospital Foundation, and Cancer Council Queensland.